Bronchitis More Resistant to Antibiotics
Posted on: Tuesday, 14 August 2007, 18:18 CDT
First-line antibiotics such as amoxicillin and ampicillin are becoming ineffective in treating
chronic bronchitis, U.S. and Greek researchers say.
Second-line antibiotic use in patients with acute exacerbation of chronic bronchitis is becoming greater because of an increase in first-line drug resistance among those with chronic bronchitis, reported a study published in the journal Chest.
To compare the effectiveness of first- and second-line antibiotics, researchers evaluated patients with acute exacerbation of chronic bronchitis from 12 randomized control trials.
The researchers found that second-line antibiotics were more effective and that there was no difference in mortality or safety, when compared with first-line antibiotics, the study said.
Source: United Press International
Related Articles
- CN's executive vice-president Sales and Marketing to address the Wolfe Research Second Annual Global Transportation Conference May 20
- Cubist Pharmaceuticals Testifies on Need to Encourage Antibiotic Research and Development
- Raptor Networks Technology to Present at California Equity Research Second Annual Southern California Investor Conference
- New Program Encourages Athletes to Aim for the Finish Line for Prostate Cancer Research
- Jon Peddie Research: Second Quarter PC Graphics Shipments Down 4.6% Sequentially, Rise 16.6% Year-Over-Year; Notebook Graphics Shipments Set a Record, Grow Nearly 32% Year-Over-Year
- Fatigue Gene Isolated: With Discovery of Mutation That Inhibits Stress Response and Causes Chronic Syndrome, Researchers Hope to Improve Patient Care
- Graphic Packaging's Quilt Wave(TM) -- The Latest Innovation In The MicroRite(R) Line Of Microwave Packaging -- Wins Second Award
- Antibiotics Research Disappoints Scientists
- AT&T Will Use SBC Lines in Illinois While Researching Alternatives, Says CEO
 |
 |
User Comments (0)
RSS Feeds